IL1B and rheumatoid arthritis: IL-1Ra is a direct inhibitor of IL-1β, and it acts by competing with the cytokines for the binding to IL-1 receptor 1 [52], to the extent that IL-1Ra-based treatments have been developed for rheumatoid arthritis and other autoinflammatory diseases [53].